Nova Mentis Life Science Corp.: Novel Therapeutic Solutions are Needed as Autism Rates Increase

Vancouver, British Columbia--(Newsfile Corp. - March 29, 2023) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and global leader

Related Keywords

Vancouver ,British Columbia ,Canada ,United States ,United Kingdom ,British ,Canadian ,Marvins Hausman , ,Neither The Canadian Securities Exchange ,Nova Mentis Life Science Corp ,Facebook ,Company The ,Canadian Securities Exchange ,Octagon Media Corp ,British Columbia Newsfile Corp ,European Union ,Centers For Disease ,Instagram ,Twitter ,Health Canada ,Mentis Life Science ,Disease Control ,Wall Street Reporter ,Market Regulator ,Nova Mentis Life Science ,Diese Gold Aktie ,Sichern Sie ,Nova ,Eventis ,Life ,Science ,Orp ,Novel ,Herapeutic ,Solutions ,Eeded ,Autism ,Rates ,Increase ,